Table 6.
Crude | Age-adjusted | Age, stage-adj. | Final Model ** | |||||
---|---|---|---|---|---|---|---|---|
OR | CI | OR | CI | OR | CI | OR | CI | |
Occupation | ||||||||
Housewife | 1 | 1 | 1 | |||||
Manual | 0.73 | 0.37-1.43 | 0.72 | 0.36-1.41 | 0.68 | 0.34-1.34 | ||
Skilled/Other | 1.41 | 0.78-2.57 | 1.28 | 0.69-2.36 | 1.15 | 0.62-2.14 | ||
Education | ||||||||
None | 1 | 1 | 1 | |||||
Primary | 1.24 | 0.84-1.84 | 1.10 | 0.72-1.68 | 1.09 | 0.71-1.67 | ||
>Primary | 1.04 | 0.50-2.17 | 0.88 | 0.41-1.89 | 0.75 | 0.35-1.65 | ||
Marital status | ||||||||
Married/regular partner | 1 | 1 | 1 | |||||
Widow/separated/other | 0.92 | 0.62-1.35 | 1.01 | 0.67-1.51 | 0.98 | 0.66-1.48 | ||
Last menstrual period | ||||||||
<12 months ago | 1 | 1 | 1 | |||||
>12 months ago | 0.90 | 0.62-1.31 | 1.20 | 0.75-1.93 | 1.25 | 0.77-2.01 | ||
Age | ||||||||
Continuous (10 year) | 0.88 | 0.76-1.01 | 0.89 | 0.77-1.03 | 0.87 | 0.75-1.01 | ||
Age at marriage | ||||||||
Continuous | 0.98 | 0.94-1.02 | 0.97 | 0.93-1.01 | 0.97 | 0.93-1.02 | ||
Gravidity | ||||||||
Continuous | 1.03 | 0.97-1.09 | 1.07 | 1.00-1.14 | 1.06 | 0.99-1.13 | ||
Year of first treatment appointment | ||||||||
Continuous (2 year) | 0.85 | 0.73-1.00* | 0.85 | 0.72-1.00* | 0.85 | 0.73-1.00 | 0.85 | 0.72-1.00* |
Place of residence | ||||||||
Dar es Salaam | 1 | 1 | 1 | 1 | ||||
Other Region | 1.40 | 0.96-2.04 | 1.48 | 1.01-2.16 | 1.44 | 0.98-2.13 | 1.46 | 0.99-2.15 |
Treatment clinic disease stage | ||||||||
Continuous | 0.73 | 0.55-0.96 | 0.74 | 0.56-0.97 | 0.72 | 0.55-0.96 | ||
Attended another health facility before screening | ||||||||
No | 1 | 1 | 1 | |||||
Yes | 1.32 | 0.82-2.11 | 1.31 | 0.82-2.10 | 1.31 | 0.81-2.11 | ||
Prescribed ≥40 Gy radiation *** | ||||||||
No | 1 | 1 | 1 | |||||
Yes | 2.29 | 1.39-3.75 | 2.17 | 1.32-3.59 | 1.88 | 1.08-3.25 | ||
Follow-up time | ||||||||
Continuous (1 week) | 1.00 | 0.98-1.02 | 1.00 | 0.98-1.02 | 1.00 | 0.98-1.02 |
*Significant at the α = 0.05 level, CI includes 1.00 due to rounding.
**Final model adjusted for age, year of first treatment appointment, place of residence, and treatment clinic disease stage.
***Prescribed ≥40 Gy radiation was not included in the final model because it is an intermediate variable between disease stage and radiation completion.